Adar Poonawalla’s company Serum Institute of India has got permission from the country’s drug regulator (DCGI) to make the Russian COVID-19 vaccine Sputnik V.
According to information received from sources, Poonawalla’s company will test, analyze and then manufacture the vaccine at its Pune-based plant.
Actually, the company had applied to DCGI a few days ago for testing, analysis and manufacturing of the vaccine.
Serum Institute of India spokesperson told media that we have got the primary approval for Sputnik V but in reality it will take a few more months to manufacture this vaccine. During this time, our focus will be on Covishield and Covaxin. Adar Poonawalla’s company is manufacturing Corona’s vaccine Covishield.
SII has got the test license for this Russian vaccine. This means that this license has been given for the purpose of testing or manufacturing the vaccine. The vaccine cannot be sold under this license.
Apart from Covishield in India, Bharat Biotech’s Covaxin and Russia’s Sputnik V have also been approved for emergency use. So far, Sputnik V is being manufactured by Dr Reddy’s Laboratories. This vaccine is registered in more than 65 countries.